synthesis of new Δ 2 -isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonists
- 1 April 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 6 (4) , 401-408
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- BMS-187257, a potent, selective, and novel heterocyclic β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1996
- Conformationally restrained β-blocking oxime ethers. 3. Synthesis and β-adrenergic antagonistic activity of diastereomeric anti and syn 2-(5′-(3′-methyl)isoxazolidinyl)-N-alkylethanolaminesEuropean Journal of Medicinal Chemistry, 1996
- Conformationally restrained β-blocking oxime ethers. 2. Synthesis and β-adrenergic properties of diastereoisomeric anti and syn 2-(5′-(3′-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines☆European Journal of Medicinal Chemistry, 1994
- Conformationally restrained β-blocking oxime ethers: synthesis and β-adrenergic properties of diastereoisomeric anti and syn 2-(5′-isoxazolidinyl)-ethanolaminesEuropean Journal of Medicinal Chemistry, 1992
- The specific binding of broxaterol, a new β2-selective agonist, to β-adrenoceptorsEuropean Journal of Pharmacology, 1991
- Chemoenzymatic synthesis of chiral isoxazole derivativesThe Journal of Organic Chemistry, 1989
- New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent .beta.-adrenergic blocking propertiesJournal of Medicinal Chemistry, 1985
- An interdisciplinary approach to the design of new structures active at the .beta.-adrenergic receptor. Aliphatic oxime ether derivativesJournal of Medicinal Chemistry, 1985
- Synthesis and .beta.-adrenergic blocking activity of new aliphatic and alicyclic oxime ethersJournal of Medicinal Chemistry, 1984
- Synthesis and .beta.-adrenergic blocking activity of new aliphatic oxime ethersJournal of Medicinal Chemistry, 1980